About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
MF Scheme SnapShots
Check out details of a particular scheme along with the latest NAV for various time periods. You can widen your search on the basis of the Fund House, Category and particular Scheme.
ITI Pharma & Healthcare Fund-Reg(G)
 
Summary
Fund Name ITI Mutual Fund  
Scheme Name ITI Pharma & Healthcare Fund-Reg(G)  
AMC ITI Asset Management Limited  
Type Open ended scheme  
Category Equity - Sectoral Fund - Pharma & Health Care  
Launch Date 08-Nov-21  
Fund Manager Animesh Singh , Nilay Dalal  
Face Value 10  
Custodian Deutsche Bank A.G.  
Net Assets (Rs. cr) 229.56  
AMC Details
ITI Asset Management Limited
ITI House, 36,
R K Shirodkar Marg, Parel
Mumbai - 400 012
Phone : 022-69153500
Fax :
mfassist@itiorg.com
www.itiamc.com
Registrar & Transfer Agent Details
KFin Technologies Limited
301, Centrium, 3rd Floor, 57, L.B.S. Road
Nav Pada, Kurla (West)
Mumbai - 400070
022 - 4617 0911
investorsupport.mfs@kfintech.com
https://mfs.kfintech.com/
 
 
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Scores| Policies of JFSL
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE| Rights and obligation| SARAL Form
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.